Charles River Laboratories
Corbyn Lamy is an experienced professional in the field of laboratory sciences, currently serving as Associate Scientific Director at Charles River Laboratories since August 2018, where responsibilities include designing and performing GLP method validations in compliance with FDA and EMA guidelines and managing sponsor relationships. Prior roles at Charles River Laboratories encompass various positions such as Research Scientist II and Research Scientist I, where similar validation duties were performed. Lamy's career started at Agilux Laboratories, contributing as an Associate Scientist I and Associate Scientist, and earlier experience includes academic support roles at Worcester Polytechnic Institute and a flooring installation position. Lamy holds a Master of Science in Pharmacology and Toxicology from Michigan State University College of Osteopathic Medicine and a Bachelor of Science with distinction in Biology and Biotechnology from Worcester Polytechnic Institute.
This person is not in any teams
This person is not in any offices
Charles River Laboratories
16 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.